Please login to the form below

Not currently logged in
Email:
Password:

cell and gene therapies

This page shows the latest cell and gene therapies news and features for those working in and with pharma, biotech and healthcare.

MedCity sets up advanced therapy research network

MedCity sets up advanced therapy research network

The UK’s  life sciences hub MedCity has launched an initiative to foster greater collaboration between industry and academia in cell, tissue and gene therapies. ... The government-funded Cell and Gene Therapy Catapult is currently building a £55m

Latest news

  • Novartis: pipeline will generate 60 filings in three years Novartis: pipeline will generate 60 filings in three years

    Novartis is showcasing its R&D pipeline at an event in London today, pledging to make no fewer than 60 'major' submissions from 2019 to 2021 across its drug, cell and ... Advanced therapy medicinal products. Novartis’push into advanced therapy

  • CHMP backs Spark’s Luxturna, but rejects Sarepta again CHMP backs Spark’s Luxturna, but rejects Sarepta again

    The EMA’s advisory committee recommended approval of Luxturna (voretigene neparvovec), for the treatment of adults and children suffering from inherited retinal dystrophy (IRD) caused by RPE65 gene mutations, a rare ... Once approved, Luxturna will be

  • Bluebird’s first gene therapy gets European fast track Bluebird’s first gene therapy gets European fast track

    Gene therapy company Bluebird Bio is on course to file its first product later this year, and has just been granted an accelerated review by the European Medicines Agency. ... Bluebird’s products are part of a wave of new cell and gene therapies

  • AZ makes gene therapy move with 4DMT alliance AZ makes gene therapy move with 4DMT alliance

    therapy medicinal products (ATMPs) such as gene and cell therapies, other than indirectly – for example its collaboration pairing a Juno CAR-T therapy with its immune checkpoint inhibitor Imfinzi (durvalumab). ... While enormously exciting gene therapy

  • Abingworth raises $315m to expand hunt for promising biotechs Abingworth raises $315m to expand hunt for promising biotechs

    There is clearly still a lot of interest in the sector and while investors tend to be more cautious and selective, recent events such as the approvals of new cell and ... gene therapies have reinvigorated biotech’s access to venture funding and

More from news
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    New disruptive innovation is changing the way we create value in healthcare: big data, artificial intelligence, the growing role of patients, the discovery of new materials and biologics, gene, cell and ... This involves incorporating new diagnostic

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    Cell and gene therapies are not just revolutionising clinical outcomes, but also in how healthcare systems administer treatment to patients, and how those healthcare systems will pay for them. ... Cell and gene therapies undoubtedly do pose difficult

  • No incentive for a cure No incentive for a cure

    Cell and gene therapies in particular are heralding remarkable curative medicines, which are given only once, or over the short term. ... And it is a revolution. that is happening right now; there are many such therapies in company pipelines, several of

  • The good, the bad and the ugly The good, the bad and the ugly

    Merck’s success in oncology will likely continue, driven by Keytruda’s lead in the frontline non-small cell lung cancer setting, ”says Cai Xuan, senior analyst, oncology and haematology, GlobalData. ... It will also be interesting to see how gene

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    This hypothetical evaluation highlights that, while certain parameters may be relaxed for cell and gene therapies, the established requirements for safety, efficacy and cost-effectiveness will still apply. ... Manufacturers of cell and gene therapies

More from intelligence
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Abeona Therapeutics appoints new additions to board of directors Abeona Therapeutics appoints new additions to board of directors

    Abeona Therapeutics, a clinical stage biopharmaceutical company focused on developing cell and gene therapies, has expanded its board of directors through the appointment of Stefano Buono and Richard Van Duyne. ... He said: “Abeona’s ambitious gene

  • Avita Medical appoints CEO Avita Medical appoints CEO

    chief scientific officer, global business development and licensing, and chief scientific officer for its cell and gene therapy unit. ... and gene therapies for Novartis subsidiaries Systemix Inc.

  • Paul Blake joins Oxford BioMedica Paul Blake joins Oxford BioMedica

    Paul Blake joins Oxford BioMedica. He will lead the development of pipeline of gene and cell therapies. ... He will head the clinical development of the company's pipeline of gene and cell therapies.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    Novel technologies, coupled with programmes designed to drive cell and gene research and development, are ushering in a new era of therapies. ... From dream to reality. The approval of two CAR-T therapies this year illustrates how cell and gene therapies

  • Introduction to the manufacturing of biologics

    However, the broad definition of a biologic is they are created by either a microorganism or a mammalian cell, and are large, complex molecules; the majority of which are proteins ... include blood or blood products, gene therapies, vaccines, and cell

  • Life at the end of the Brexit tunnel

    An Advanced Therapies Treatment Centre to develop cell and gene therapies. ... Expansion of the Cell and Gene Therapy Manufacturing Centre in Stevenage.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics